US FDA Focuses On Labs, Concomitant Medication To Avert Needless Clinical Trial Exclusions

 
• By Sarah Karlin-Smith
  
dozens of portraits of people to emphasize diversity
New FDA guidance aims to boost trial diversity with more inclusive trial eligibility criteria. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D